138 related articles for article (PubMed ID: 25196917)
1. Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis.
van der Velden WJ; Herbers AH; Netea MG; Blijlevens NM
Br J Haematol; 2014 Nov; 167(4):441-52. PubMed ID: 25196917
[TBL] [Abstract][Full Text] [Related]
2. Febrile mucositis in haematopoietic SCT recipients.
van der Velden WJ; Blijlevens NM; Feuth T; Donnelly JP
Bone Marrow Transplant; 2009 Jan; 43(1):55-60. PubMed ID: 18762766
[TBL] [Abstract][Full Text] [Related]
3. Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.
Blijlevens NM; Donnelly JP; de Pauw BE
Clin Microbiol Infect; 2001; 7 Suppl 4():47-52. PubMed ID: 11688534
[TBL] [Abstract][Full Text] [Related]
4. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Mucositis: from febrile neutropenia to febrile mucositis.
Blijlevens NM; Logan RM; Netea MG
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i36-40. PubMed ID: 19372181
[TBL] [Abstract][Full Text] [Related]
5. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
Shenep JL
NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
[TBL] [Abstract][Full Text] [Related]
6. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy.
Zecha JAEM; Raber-Durlacher JE; Laheij AMGA; Westermann AM; Epstein JB; de Lange J; Smeele LE
Support Care Cancer; 2019 Oct; 27(10):3667-3679. PubMed ID: 31222393
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
[TBL] [Abstract][Full Text] [Related]
8. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
9. The role of oral mucositis on the systemic inflammation parameter IL-8 in febrile neutropenic cancer patients.
Stokman MA; Oude Nijhuis CS; Spijkervet FK; de Bont ES; Dijkstra PU; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Kamps WA
Cancer Invest; 2006; 24(5):479-83. PubMed ID: 16939955
[TBL] [Abstract][Full Text] [Related]
10. Infection in neutropenic patients with cancer.
Bow EJ
Crit Care Clin; 2013 Jul; 29(3):411-41. PubMed ID: 23830647
[TBL] [Abstract][Full Text] [Related]
11. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
13. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
14. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
Latiff Z; Zulkifli SZ; Jamal R
Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
17. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
18. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.
Blijlevens NM; Donnelly JP; De Pauw BE
Bone Marrow Transplant; 2000 Jun; 25(12):1269-78. PubMed ID: 10871732
[TBL] [Abstract][Full Text] [Related]
19. Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients.
Herbers AH; de Haan AF; van der Velden WJ; Donnelly JP; Blijlevens NM
Transpl Infect Dis; 2014 Apr; 16(2):279-85. PubMed ID: 24621081
[TBL] [Abstract][Full Text] [Related]
20. [Fever profile of febrile neutropenia in patients treated with cancer chemotherapy for hematological malignancies].
Tamai Y; Imataki O; Kawakami K
Gan To Kagaku Ryoho; 2010 May; 37(5):859-62. PubMed ID: 20495316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
